Friday, Jul 24, 2026 The claims desk. Receipts included. POWERED BY LENZ ↗
IsThis

HEALTH

The Claim

Among patients 12 months after ST-elevation myocardial infarction, those with high-sensitivity C-reactive protein levels greater than 26.4 mg/L had a 12% rate of major adverse cardiovascular events, compared with a 4% rate among those with high-sensitivity C-reactive protein levels at or below 26.4 mg/L.

Verified by Lenz ·

The Short Version

The quoted 12% versus 4% event rates are supported by a 2024 peer-reviewed STEMI study. However, those numbers came from a selected cohort followed for about 12 months, and the 26.4 mg/L threshold was the study’s median hs-CRP level, not a broadly accepted universal cutoff. The data are accurate, but the wording is slightly broader than the underlying evidence.

Caveats

  • The 26.4 mg/L threshold was a study-specific median value, not a standard clinical hs-CRP cutoff used across cardiology.
  • The reported rates came from a particular STEMI cohort with cardiac MRI follow-up, so they should not automatically be generalized to all STEMI patients.
  • The phrasing can be read as a fixed 12-month landmark result, while the study reported cumulative events over roughly 12 months of follow-up.

The Receipts

  1. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction

    PubMed

  2. The prognostic role of high-sensitivity C-reactive protein in patients with acute ST-elevation myocardial infarction

    PubMed Central

  3. Association of Intramyocardial Hemorrhage With Inflammatory Biomarkers and Clinical Outcome in ST-Segment–Elevation Myocardial Infarction

    PubMed Central (JACC: Cardiovascular Imaging)

  4. High-Sensitivity C-Reactive Protein as a Predictor of Cardiovascular Events after ST-Elevation Myocardial Infarction

    PubMed Central

  5. C-Reactive Protein as a Risk Marker for Post-Infarct Heart Failure and Cardiac Events in Patients With ST-Elevation Myocardial Infarction

    PubMed Central (Cardiovascular Drugs and Therapy)

  6. Prioritizing Health | hsCRP: A Promising Risk Assessment Tool

    American College of Cardiology

  7. Increased High Sensitive C-reactive Protein is Associated with Major Adverse Cardiovascular Events in Patients with ST-elevation Myocardial Infarction

    Medical Principles and Practice (via Semantic Scholar PDF)

  8. Initial systolic blood pressure associates with systemic inflammation and outcome in acute coronary syndromes

    European Heart Journal – Acute Cardiovascular Care (PDF hosted by ZHH)

  9. High-sensitivity C-reactive protein and prognosis in patients with acute ST-elevation myocardial infarction

    PubMed

  10. C-reactive Protein (CRP) Levels as a Predictor of Adverse Outcomes in Acute Myocardial Infarction Patients: A Prospective Observational Study

    PubMed Central

+ 11 more sources — see the full list on Lenz

Filed Under

High-Sensitivity C-Reactive ProteinMajor Adverse Cardiovascular EventsST-Elevation Myocardial Infarction

More Fact Checks